Global Bioenergies Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 0/6

Wichtige Informationen

46.3%

Verhältnis von Schulden zu Eigenkapital

€4.82m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	€11.84m
Eigenkapital	€10.41m
Gesamtverbindlichkeiten	€7.85m
Gesamtvermögen	€18.25m

Jüngste Berichte zur Finanzlage

Recent updates

Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?

Jun 28

Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?

Oct 11

Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?

Oct 25

Global Bioenergies (EPA:ALGBE) Shareholders Have Enjoyed An Impressive 187% Share Price Gain

Mar 20

Global Bioenergies Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?

Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?

Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?

Recent updates

New minor risk - Shareholder dilution

Global Bioenergies SA, Annual General Meeting, Jun 27, 2024

Global Bioenergies SA, Annual General Meeting, Jun 27, 2024

New major risk - Revenue and earnings growth

Consensus revenue estimates fall by 45%

Full year 2023 earnings released

Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer

First half 2023 earnings released

Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?

Consensus EPS estimates fall by 26%

Insufficient new directors

No longer forecast to breakeven

Price target decreased by 22% to €5.60

Consensus EPS estimates upgraded to €0.22 loss

Forecast to breakeven in 2025

Full year 2022 earnings released

Forecast to breakeven in 2025

Price target increased to €16.37

Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?

Price target decreased to €7.15

Global Bioenergies SA Completes REWOFUEL Project

Full year 2021 earnings: Revenues exceed analyst expectations

Global Bioenergies Announces New Molecule for the Greening of C5 Chemistry

Forecast to breakeven in 2024

Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?

First half 2021 earnings released: €0.69 loss per share (vs €0.80 loss in 1H 2020)

Global Bioenergies Launches Lip Make-Up Range for Its Last Cosmetics Brand

Global Bioenergies Releases Second Commercial Batch of Naturally Sourced Isododecane

Global Bioenergies Launches of LAST brand

No longer forecast to breakeven

Global Bioenergies Announces the Upcoming Launch of “LAST®” Longwear Cosmetics

Full year 2020 earnings released: €1.10 loss per share (vs €1.65 loss in FY 2019)

Global Bioenergies (EPA:ALGBE) Shareholders Have Enjoyed An Impressive 187% Share Price Gain

Full year 2020 earnings released

New 90-day high: €9.48

New 90-day high: €4.14

First half earnings released

New 90-day low - €2.87

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen